Search
Search results
Displaying 591 - 600 of 1798
… are currently run from Southmead Hospital for our Bristol patients and from Melksham Town Hall for our Wiltshire patients. The Mood and Food groups are a great opportunity … are currently run from Southmead Hospital for our Bristol patients and from Melksham Town Hall for our Wiltshire …
… is passionate about providing a positive experience for patients in Theatre. Acting Consultant Obstetrician & … I am member of the surgical team who deal with PAS patients at NBT. I have worked in Bristol for seven years, in … is passionate about providing a positive experience for patients in Theatre. … I am an Obstetric and Gynaecology …
… and the surgical management of cancers. Only 15-20% of patients who are referred to Bristol Urological Institute by … and the surgical management of cancers. Only 15-20% of patients who are referred to Bristol Urological Institute by …
… one to two years later if still indicated. In those patients who remain at high risk of fracture in spite of five years’ treatment with bisphosphonates, for example patients with multiple vertebral fractures or very low BMD, … one to two years later if still indicated. In those patients who remain at high risk of fracture in spite of five …
… www.vascularsociety.org.uk/patients www.kidneyresearchuk.org/health-information Living … www.vascularsociety.org.uk/patients www.kidneyresearchuk.org/health-information … …
… both relevant and accessible to the general public, to patients and their carers. Clinical research helps us … and many clinical research studies directly involve patients to see which medicines or medical treatments work … patient. At North Bristol NHS Trust each year over 7,000 patients take part in research with more than 500 research …
… to a minimum standard which minimises the risk of harm to patients. The Specimen Labelling Policy (CG-163) is attached below. Key points are: The patients primary identifier is the NHS number and this must … to a minimum standard which minimises the risk of harm to patients. The Specimen Labelling Policy (CG-163) is attached …